Riskpilot← Back to searchSign inGet full accessALSTAD LEGESENTER AS
ASActiveOrg 999301444Trålveien 56, 8013 BodøGeneral medical practice activities · NACE 8621Est. 20135 employees
Revenue 2025
NOK 5,2M
+13% vs 2024
EBITDA margin
3.5%
+228% vs 2024
Equity ratio
33.3%
Financial strength
Net profit 2025
NOK 136K
+173% vs 2024
| Revenue | NOK 5,2M | +13% |
| EBITDA | NOK 181K | +228% |
| Net profit | NOK 136K | +173% |
| Total assets | NOK 524K | +14% |
| Equity | NOK 175K | +348% |
| Employees | 5 | — |
Legal name
ALSTAD LEGESENTER AS
Org number
999301444
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
24. januar 2013
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drift av legekontor med alt som naturlig hører til dette. Legge best mulig til rette for drift av aksjonærenes legevirksomhet. Hvis aktuelt kan selskapet også eie, drifte og leie ut eiendom og andre driftsmidler.
Address
Trålveien 56, 8013 Bodø
Phone
+4775530600
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 961 | 4 300 | 4 444 | 4 628 | 5 240 |
| Staff expenses | −1 817 | −1 957 | −2 229 | −2 437 | −2 691 |
| EBITDA | 37 | 122 | 41 | −141 | 181 |
| Depreciation & amort. | −37 | −39 | −43 | −43 | −44 |
| EBIT | 1 | 83 | −2 | −184 | 137 |
| Net financials | −1 | −0 | −0 | −0 | −1 |
| Profit before tax | −0 | 83 | −2 | −185 | 136 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −0 | 83 | −2 | −185 | 136 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 454 | 603 | 533 | 458 | 524 |
| Equity | 143 | 226 | 223 | 39 | 175 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 311 | 377 | 310 | 419 | 349 |
| Total debt | 311 | 377 | 310 | 419 | 349 |
EBITDA margin
3.5%
This company
15.8%
Market median
-78% vs market
20212025
Equity ratio
33.3%
This company
38.2%
Market median
+13% vs market
20212025
Return on equity
77.7%
This company
18.4%
Market median
+322% vs market
20212025
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20212025
Asset turnover
10.00×
This company
1.12×
Market median
+793% vs market
20212025
Debt / equity
2.00×
This company
0.62×
Market median
-223% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2020 – 2023 | |
| Board of Directors | 2020 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ALSTAD LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Kvale Loe | Board of Directors | 0 companies |
| Nora Snefjellå | Board of Directors | 0 companies |